It has been demonstrated that IL4 was able to improve insulin sensitivity and glucose tolerance in an animal model of diet induced obesity [53], therefore its up-regulation could be a tentative to restore insulin sensitivity, which is a common pathogenetic mechanism in DM and NASH. Here, IL4 is linked to metabolic dysfunction-associated steatohepatitis.